YHR073W-A Antibody

What is YHR073W-A and what is its biological significance?

YHR073W-A (UniProt accession P0C5N7) is a protein-coding gene in Saccharomyces cerevisiae (strain ATCC 204508 / S288c), commonly known as baker's yeast. The protein encoded by this gene belongs to a family of proteins with conserved functions across yeast strains. Understanding YHR073W-A's function contributes to broader knowledge of yeast cellular processes, particularly in protein expression systems that are frequently used as models for eukaryotic cellular mechanisms. The antibody against this protein enables researchers to detect, quantify, and isolate the protein from complex biological samples .

How are YHR073W-A antibodies generated for research applications?

YHR073W-A antibodies are typically generated through recombinant protein expression systems or synthetic peptide immunization strategies. For polyclonal antibodies, purified YHR073W-A protein or synthetic peptides corresponding to immunogenic regions are used to immunize host animals (commonly rabbits). For monoclonal antibodies, B cells from immunized mice are isolated and fused with myeloma cells to create hybridomas that secrete antibodies with a single specificity. The resulting antibodies undergo rigorous validation including Western blotting, immunoprecipitation, and sometimes mass spectrometry to confirm specificity against the target protein in yeast lysates.

What validation steps are essential before using YHR073W-A antibodies in critical experiments?

Before employing YHR073W-A antibodies in key experiments, researchers should conduct comprehensive validation through multiple complementary approaches:

• Western blot analysis using both wild-type yeast and YHR073W-A knockout strains

• Peptide competition assays to confirm binding specificity

• Immunoprecipitation followed by mass spectrometry to verify target capture

• Cross-reactivity testing against related yeast proteins

• Dilution series to establish optimal working concentration

These validation steps are particularly important when studying proteins in S. cerevisiae as yeast contains numerous homologous proteins that may cross-react with antibodies, potentially yielding misleading results in downstream applications.

How should researchers optimize Western blot protocols specifically for YHR073W-A detection?

When optimizing Western blot protocols for YHR073W-A detection, researchers should consider:

• Sample preparation: Use spheroplasting with zymolyase followed by gentle lysis to preserve protein integrity

• Electrophoresis conditions: 12-15% SDS-PAGE gels are typically optimal for resolving yeast proteins in this molecular weight range

• Transfer parameters: Semi-dry transfer at 15V for 30 minutes or wet transfer at 30V overnight at 4°C

• Blocking optimization: 5% non-fat dry milk in TBST is generally effective, though BSA may yield better results for phospho-specific detection

• Antibody dilution: Start with 1:1000 dilution and adjust based on signal-to-noise ratio

• Signal detection: ECL substrates with moderate sensitivity are typically sufficient; avoid excessive exposure which may lead to non-specific background

Researchers should also include appropriate controls including YHR073W-A knockout strains and positive controls expressing tagged versions of the protein to confirm specificity.

How can YHR073W-A antibodies be effectively utilized in co-immunoprecipitation studies?

For co-immunoprecipitation (co-IP) studies investigating protein-protein interactions involving YHR073W-A:

• Cell lysis conditions must preserve native protein complexes; use buffers containing 0.1-0.5% NP-40 or Triton X-100 with protease inhibitors

• Pre-clear lysates with protein A/G beads to reduce non-specific binding

• Immobilize YHR073W-A antibody on protein A/G beads at 4°C for 1-2 hours before adding pre-cleared lysate

• Incubate overnight at 4°C with gentle rotation to maintain complex integrity

• Wash stringently (at least 5 times) with cold lysis buffer to remove non-specific interactions

• Elute with either low pH glycine buffer or by boiling in SDS sample buffer

• Analyze interacting partners by Western blot or mass spectrometry

This method can be particularly valuable for understanding the functional role of YHR073W-A within protein complexes involved in endoplasmic reticulum processes, similar to approaches used in studying protein folding environments .

What considerations are important when using YHR073W-A antibodies for immunofluorescence microscopy in yeast cells?

When performing immunofluorescence microscopy with YHR073W-A antibodies in yeast:

• Fixation method: 3.7% formaldehyde for 1 hour followed by zymolyase treatment to create spheroplasts

• Cell wall digestion: 0.5-1.0 mg/ml zymolyase-100T in sorbitol buffer for 30 minutes at 30°C

• Permeabilization: 0.1% Triton X-100 for 10 minutes (critical for antibody access)

• Blocking: 1% BSA and 0.1% Tween-20 in PBS for 30-60 minutes

• Primary antibody incubation: Overnight at 4°C at dilutions of 1:100 to 1:500

• Secondary antibody selection: Highly cross-adsorbed fluorophore-conjugated antibodies to minimize background in yeast cells

• Mounting: Use anti-fade mounting media containing DAPI for nuclear counterstaining

The small size of yeast cells requires high-resolution imaging techniques such as confocal microscopy with deconvolution for optimal visualization of subcellular localization patterns.

How should quantitative Western blot data for YHR073W-A be properly normalized and analyzed?

For rigorous quantification of YHR073W-A expression by Western blotting:

• Use housekeeping protein controls appropriate for yeast (Pgk1, Adh1, or Act1)

• Implement technical replicates (minimum 3) across independent biological samples

• Ensure signal linearity by testing multiple sample dilutions

• Quantify band intensities using software like ImageJ with background subtraction

• Normalize target protein to loading control within each lane

• Apply appropriate statistical tests for comparing conditions (t-test for two conditions, ANOVA for multiple conditions)

• Report both raw and normalized values with error bars representing standard deviation or standard error

The quantification should account for exposure differences between blots when comparing samples across multiple experiments.

What approaches help resolve contradictory results when using different detection methods for YHR073W-A?

When faced with contradictory results from different detection methods:

• Evaluate antibody specificity in each application through knockout/knockdown controls

• Consider epitope accessibility differences between methods (native vs. denatured conditions)

• Implement orthogonal detection methods (e.g., mass spectrometry) that don't rely on antibody recognition

• Assess post-translational modifications that may affect antibody binding in different contexts

• Compare results with tagged versions of YHR073W-A (e.g., HA, FLAG, or GFP fusions)

• Examine potential interfering factors specific to each method (e.g., cross-reactivity or autofluorescence)

• Consult published literature for known technical challenges with similar yeast proteins

Resolution often requires a multi-method approach similar to those employed in HIV-1 envelope protein studies where antibody recognition can be context-dependent .

What strategies can address non-specific binding when using YHR073W-A antibodies?

To minimize non-specific binding issues:

• Optimize blocking conditions: Test different blocking agents (milk, BSA, fish gelatin) at varying concentrations (1-5%)

• Increase washing stringency: Use higher salt concentrations (up to 500mM NaCl) in wash buffers

• Implement additives: Include 0.1-0.5% Tween-20 or 0.1% Triton X-100 in antibody dilution buffers

• Pre-adsorb antibody: Incubate with acetone powder from YHR073W-A knockout yeast

• Titrate antibody concentration: Perform a dilution series to find optimal signal-to-noise ratio

• Use competition assays: Pre-incubate antibody with immunizing peptide to confirm specificity

• Consider alternative antibody clones if available

These optimization strategies should be systematically tested and documented for reproducibility in future experiments.

How can researchers distinguish between technical failures and true negative results when working with YHR073W-A antibodies?

To differentiate between technical failures and true negative results:

• Include positive controls: Use samples known to express YHR073W-A or recombinant protein standards

• Implement internal controls: Detect housekeeping proteins simultaneously to confirm successful technique

• Validate antibody functionality: Test the same antibody lot on confirmed positive samples

• Assess detection limits: Determine minimum detectable protein amount through standard curves

• Consider alternative detection methods: Compare results across multiple techniques (Western blot, ELISA, immunofluorescence)

• Evaluate experimental conditions: Check protein extraction efficiency, sample degradation, and assay parameters

• Document antibody performance: Maintain records of antibody lot validation and performance history

This systematic approach helps distinguish biological findings from technical artifacts, similar to the methodical validation employed in antibody studies for SARS-CoV-2 .

What methodological approaches enable studying temporal dynamics of YHR073W-A expression under stress conditions?

To study temporal dynamics of YHR073W-A expression during stress responses:

• Time-course experimental design: Collect samples at multiple timepoints after stress induction

• Quantitative Western blotting: Perform as described in section 4.1

• RT-qPCR: Monitor transcript levels in parallel with protein expression

• Live-cell imaging: Use GFP-tagged YHR073W-A for real-time monitoring

• Flow cytometry: Quantify expression levels in large populations of fixed and permeabilized cells

• Pulse-chase analysis: Track protein synthesis and degradation rates using metabolic labeling

• Single-cell analysis: Employ microfluidic devices combined with fluorescence microscopy

This multi-faceted approach provides comprehensive insights into both transcriptional and post-transcriptional regulation during stress responses, similar to approaches used in endoplasmic reticulum stress studies .

How can researchers effectively employ YHR073W-A antibodies in chromatin immunoprecipitation (ChIP) experiments?

For successful chromatin immunoprecipitation using YHR073W-A antibodies:

• Crosslinking optimization: Test both formaldehyde concentrations (1-3%) and crosslinking times (10-30 minutes)

• Chromatin fragmentation: Optimize sonication parameters to achieve 200-500bp fragments

• Pre-clearing: Use protein A/G beads with non-immune IgG to reduce background

• Antibody selection: Choose ChIP-validated antibody lots or perform validation experiments

• Washing stringency: Include high-salt and LiCl washes to remove non-specific interactions

• Elution and reversal: 65°C overnight incubation followed by RNase and proteinase K treatment

• qPCR primer design: Target regions with predicted binding sites and include negative control regions

When studying DNA-binding proteins, it's critical to confirm whether YHR073W-A directly interacts with DNA or associates with chromatin through protein-protein interactions with known DNA-binding factors.